 Home > Medical News > Latest Medical News > Hengrui Medicine's new drug for dry eye disease successfully plans to be reported for listing in Phase III clinical trials

Hengrui Medicine's new drug for dry eye disease successfully plans to be reported for listing in Phase III clinical trials

 Last Update: 2022-01-12
 Source: Internet
 Author: User

Tags

product research

safe zone

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 30, Hengrui Medicine announced that SHR8058 eye drops for the treatment of meibomian gland dysfunction-related dry eye disease is a multi-center, randomized, double-blind, salt solution parallel controlled phase III clinical trial (SHR8058-301) that has achieved the main research endpoint results.

The results of the phase III study showed that compared with placebo, SHR8058 eye drops can treat dry eye related to meibomian gland dysfunction and significantly improve the symptoms and signs of dry eye in patients

The SHR8058-301 study is a multi-center, randomized, double-blind, salt solution parallel controlled phase III clinical trial that evaluates the effectiveness and safety of SHR8058 eye drops in the treatment of dry eye related to meibomian gland dysfunction.

A total of 312 subjects with dry eye related to meibomian gland dysfunction were enrolled in this study.

SHR8058 eye drops is a product introduced by Hengrui from NovaliqGmbH in November 2019.

SHR8058 eye drops is a colorless, transparent eye drops composed of 100% perfluorohexyl octane, which can quickly spread to the entire ocular surface and interact with the lipophilic part of the tear film to stabilize the tear film and prevent The tears evaporate excessively

Up to now, SHR8058 related projects have invested a total of approximately 68.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.